Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | NVAX | Common Stock | Options Exercise | +10K | +15.36% | 75.1K | Jul 1, 2021 | Direct | F1 | ||
holding | NVAX | Common Stock | 1.5K | Jul 1, 2021 | By spouse | F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | NVAX | Restricted Stock Units | Options Exercise | $0 | -10K | -100% | $0.00* | 0 | Jul 1, 2021 | Common Stock | 10K | Direct | F1, F3 |
Id | Content |
---|---|
F1 | Each restricted stock unit ("RSU") represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock. |
F2 | The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose. |
F3 | Fifty percent (50%) of the RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested on January 1, 2021 and the remaining fifty percent (50%) vested on July 1, 2021, in each case subject to continued service on the Company's Board of Directors through such vesting date. |